CMS Open Payments · Program Year 2024
Gentleman Orthopedic Solutions
Gentleman Orthopedic Solutions reported $19,955.59 across General Payments, Research, and Ownership to 136 physicians and teaching hospitals across 136 transactions.
- $20.0K Below-median payer
- All-tracks total
- 136 Below-median volume
- Transactions
- 136 Above-median reach
- Recipients
- +$928.71
- General Payments vs PY2023
Gentleman Orthopedic Solutions reported $19,955.59 across all CMS Open Payments tracks (General + Research + Ownership) to 136 physicians and teaching hospitals in Program Year 2024 - ranking #1535 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $19,955.59, averaging $146.73 per recipient.
How Gentleman Orthopedic Solutions's $20.0K all-tracks total breaks down
Gentleman Orthopedic Solutions's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
14/100
Total payments
F
10/100
Transaction volume
F
11/100
Physician reach
F
11/100
Payment type diversity
F
23/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer gentleman-orthopedic-solutions Gentleman Orthopedic Solutions
$20.0K · #1535/1,925 · 0.0% industry · PY2024
- TOT $20.0K
- RANK #1535
- SHARE 0.0%
- TXN 136
- RCP 136
- CAT 2
- GEN $20.0K
- ΔGEN +$928.71
- TOP1 9.7%
- PY 2024
Volume peers
Nearest volume peer: Belluscura LLC ($20.0K)
Gentleman Orthopedic Solutions sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Gentleman Orthopedic Solutions's CMS-reported General Payments increased by $928.71 (+4.9%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: GENTLEMAN ORTHOPEDIC SOLUTIONSPY2023: GENTLEMAN ORTHOPEDIC SOLUTIONSPY2024: Gentleman Orthopedic Solutions. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $19,026.88
- PY2024
- $19,955.59
What the Data Shows for Gentleman Orthopedic Solutions
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Gentleman Orthopedic Solutions, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
"Food and Beverage" leads the 2-category general-payment breakdown below at $10.6K (53.2% of General Payments, 122 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
Across 2 types of general payments, Gentleman Orthopedic Solutions's largest category was "Food and Beverage" at $10.6K - 53.2% of General Payments.
How Gentleman Orthopedic Solutions divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $10.6K | 122 | 53.2% |
| Travel and Lodging | $9.3K | 14 | 46.8% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $7,691.74 (38.5%) of $19,955.59 in this company's General Payments records across 70 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Gentleman Orthopedic Solutions
The five named recipients with the highest reported General Payments from this company
- 1
David Pearce
$1,940.25 across 4 reported transactions
- 2
David Brown
$1,918.04 across 4 reported transactions
- 3
Carson Rider
$1,736.22 across 5 reported transactions
- 4
Chad Altmyer
$1,055.92 across 3 reported transactions
- 5
James Hurt III
$1,041.31 across 5 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Gentleman Orthopedic Solutions's spend rank (#1535 of 1,925, bottom 20% by spend) and concentration rank (#1,335 of 1,838, bottom 27% least concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- OrthoPediatrics Corp. : $2.7M total payments, HHI 449
- Rhythm Pharmaceuticals, Inc. : $177.0K total payments, HHI 449
- Linvatec Corporation : $5.3M total payments, HHI 448
- Midsouth Orthopedics Inc. : $10.7K total payments, HHI 447
- Acclarent, Inc : $232.0K total payments, HHI 447
- Pinnacle Biologics, Inc : $70.6K total payments, HHI 445
- Gentleman Orthopedic Solutions (this company) : $20.0K total payments, HHI 445
- Blue Earth Diagnostics Limited : $324.1K total payments, HHI 444
- Trilliant Surgical LLC. : $844.6K total payments, HHI 443
- Innovasis Inc : $1.1M total payments, HHI 441
- Avadel CNS Pharmaceuticals, LLC : $1.5M total payments, HHI 441
- Intrinsic Therapeutics : $300.7K total payments, HHI 441
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Gentleman Orthopedic Solutions's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Gentleman Orthopedic Solutions.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Gentleman Orthopedic Solutions.
Showing 6 of 1,924 companies with CMS-reported payment data.
OTU Medical Inc.
Medicomp Inc
Core Surgical Group
DentalEZ, Inc.
Virtus Pharmaceuticals LLC
Put this to use
Gentleman Orthopedic Solutions ranks #1535 of 1,925 by all-tracks total payments, led by "Food and Beverage".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Food and Beverage" spend across every manufacturer, not just Gentleman Orthopedic Solutions. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.